TNGX
Tango Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$17.30
+0.15 ▲ +0.87%
🌙 3월 13일 7:41 PM ET (한국 3/14 08:41)
$17.25
-0.05 ▼ -0.30%
| Index | RUT | P/E | - | EPS (ttm) | -0.86 | Insider Own | 31.5% | Shs Outstand | 0.14B | Perf Week | 2.06% |
| Market Cap | 2.47B | Forward P/E | - | EPS next Y | -15.21% | Insider Trans | -3.18% | Shs Float | 0.10B | Perf Month | 37.19% |
| Enterprise Value | 2.16B | PEG | - | EPS next Q | -0.31 | Inst Own | 92.1% | Short Float | 49.87% | Perf Quarter | 88.66% |
| Income | -0.10B | P/S | 39.57 | EPS this Y | -47.44% | Inst Trans | 13.99% | Short Ratio | 14.6 | Perf Half Y | 152.92% |
| Sales | 0.06B | P/B | 6.79 | EPS next 5Y | -23.85% | ROA | -27.5% | Short Interest | 48.74M | Perf YTD | 95.26% |
| Book/sh | 2.55 | P/C | 7.18 | EPS past 3/5Y | 10.79% 11.68% | ROE | -37.23% | 52W High | -1.87% ($17.63) | Perf Year | 830.11% |
| Cash/sh | 2.41 | P/FCF | - | Sales past 3/5Y | 35.89% 52.13% | ROIC | -26.95% | 52W Low | 1579.61% ($1.03) | Perf 3Y | 303.26% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 28.08% | Gross Margin | 96.34% | Volatility(W/M) | 5.04% 8.25% | Perf 5Y | 54.46% |
| Dividend TTM | - | EV/Sales | 34.6 | Sales Y/Y TTM | 48.29% | Oper. Margin | -178.39% | ATR (14) | 1.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 16.32 | EPS Q/Q | 15.03% | Profit Margin | -162.85% | RSI (14) | 74.64 | Recom | 1.18 |
| Dividend Gr. 3/5Y | - | Current Ratio | 16.32 | Sales Q/Q | -100% | SMA20 | 24.91% ($13.85) | Beta | 1.61 | Target Price | $19.67 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 3000000 | SMA50 | 38.32% ($12.51) | Rel Volume | 1.26 | Prev Close | $17.15 |
| Employees | 137 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | 8.86% -100% | SMA200 | 103.8% ($8.49) | Avg Volume(3M) | 3.34M | Price | $17.3 |
| IPO | 2020/9/3 | Option/Short | Yes/Yes | Trades | 21634 | Volume | 4,210,183 | Change | 0.87% |
뉴스 로딩 중...